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Editorials 
The Dillon Plan for U.S. health care 
John B Dillon MD MS BS FACP earned his medical 
degree in 1943 at the StLouis University School of Medicine. 
He became a resident at Letterman General Hospital in San 
Francisco in anesthesia, and became Chief of Anesthesia in 
1946. He not only had a long and distinguished career as an 
anesthesiologist in the California hospital systems but also on 
the faculty at UCLA, culminating as Professor of 
Anesthesiology in 1973. He has also been active in organized 
medicine with the LA County Medical Society, the California 
Medical Association and the AMA; he served 6 years as a 
member of the AMA House of Delegates. His CV fills 16 
typewritten pages. He has received numerous awards, and he 
has been published 117 times, writing not only on matters 
within his field but also on many aspects of medical practice. 
At the age of 81, he is retired and living in Koloa, Kauai. 
John Dillon is still very active, involving himself in many 
things. With such a background in medicine his opinion car-
Starting from the bottom up 
There seems to be almost universal agreement that there 
needs to be changes in the manner in which health care is pro-
vided to the people of the United States. Those who seem to dis-
agree with this are the insurance companies, who profit by the 
status quo, some physicians and other immediate providers of 
health care. Attorneys who profit by allegations of malpractice 
and negligence will also be upset when major reforms occur. 
The majority of "consumers" believe that changes in health 
care delivery are necessary. All agree that costs are excessive 
and the delivery system is uneven and discriminatory; howev-
er, there is little agreement as to how to correct the situation. 
Most will probably agree that medical care should not be 
based upon the profit motive; instead, providers should be sat-
isfied with receiving a reasonable and fair compensation. 
Almost everyone agrees that medical care is now a right. It is 
generally recognized that, like other things in life, medical 
care will not always be of the highest quality for all patients 
because those who provide it cannot always be the best and 
the brightest. There is always someone at the bottom of the 
class but nevertheless certifiable as a fully trained physician or 
other provider. Some hospitals will always be better than oth-
ers. 
However, there must be an acceptable and universal deliv-
ery of basic medical care available to satisfy every patient's 
need, not necessarily his or her wants. Whether certain exotic 
treatments should be provided for patients, where the improve-
ment gained in life expectancy or in improved function is neg-
ligible, would have to be determined. This is an ethical issue. 
It is reasonable to believe that the necessary changes will 
not come from the top. The system is too vast and entrenched. 
Medicine suffers from a severe narcissus complex. The 
changes that will come must come from the bottom. 
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ries weight, and we are happy to have him submit in this issue 
of the Journal a guest editorial on health care in the United 
States. As a long-time anesthesiologist, John has had a unique 
opportunity to assess the capabilities and vagaries of surgeons 
in particular, and of physicians in general, while holding the 
lives of their patients in his embrace. 
We hope Dillon's treatise will stimulate others within our 
noble profession to devote some of their energies to assessing 
the plethora of proposals now being bandied about nationally 
- proposals to "change things". We agree with John: That 
changes, if warranted, or modifications, for certain, should be 
devised and designed "from below", ie by us in the profession. 
We do not endorse the "Dillon Plan" in toto; it provides 
food for thought, however. 
J I Frederick Reppun MD 
Editor 
The first proposition that must be accepted is that no 
patient should ever receive a bill for medical care, nor for pre-
scription drugs (which should all be generic). All costs must 
be paid through a single carrier, rather than by the vast insur-
ance bureaucracy that now exists, with its monumental over-
head and excessive profit. 
Financing should be by taxation, eliminating the need for 
any insurance. Management of the program should be at the 
state level through a single department. Since all charges 
would be standardized there would be no incentive to pad 
bills. Patients would receive the care they need. Charges 
should be uniform and standardized, both by the individual 
health care provider and by the hospitals . All health care 
providers should be salaried and their incomes capped. 
The second proposition is that medical education must be 
modified to accommodate the revised ethic. Medical educa-
tion should be patient-oriented rather than to disease and sci-
ence. The education of medical students should be subsidized. 
For this the student should, upon completion of medical 
school and 1 year of rotating internship including obstetrics 
and pediatrics, be obligated to spend 5 years receiving a grad-
uated salary in providing primary health care under supervi-
sion. After the 5 years, the physician might apply for residen-
cy training or go into research. By this time he or she would 
be truly a full-fledged physician. 
This would obviate specialists with tunnel vision, as is so 
common today, who are highly trained technicians but with no 
knowledge or interest in the patient as a whole but only in his 
or her disease. Specialty training should be shortened. During 
that training the physician would receive a salary, starting at 
the last salary level received as a primary care physician and 
increasing every year by some amount until the residency or 
(Continued)~ 
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"The recommended starting dose for Calan SR is 180 mg once 
dally. Dose titration will be required In some patients to 
achieve blood pressure control. A lower Initial starting dosage 
of 120 mg/day may be warranted in some patients leg, the 
elder1y, patients of small stature>. Dosages above 240 mg daily 
should be administered in divided doses. Calan SR should be 
administered with food. 
tConstJpatlon. Which Is eaSilY managed In most patients. Is the most commonty 
reported skle effect Of catan SR. 
tverapamll Should be administered cautiouSly to patients with Impaired renal 
function. 
BRIEF SUMMARY 
Contralndicatlo Severe LV dysfunction (see Warnings), hypotension (systolic pressure 
< 90 mm Hg) or cardiogenic shock, sick sinus syndrome (if no pacemaker is present). 2nd· or 
3rd-degree AV block (if no pacemaker is present). atrial flutter/fibrillation with an accessory 
bypass tract (eg, WPW or LGL syndromes). hypersensitivity to verapamil. 
Wlmlngs: Verapam~ should be avoided in patients with severe LV dysfunction (eg. ejection 
fraction < 30%) or moderate to severe symptoms of cardiac failure and in patients with any 
degree of ventricular dysfunction if they are receiving a beta-blocker. Control milder heart failure 
with optimum digitalization and/or diuretics before Calan SA is used. Verapamil may occasionally 
produce hypotension. Elevations of liver enzymes have been reported. Several cases have been 
demonstrated to be produced by verapamil. Periodic monitoring of liver function in patients on 
verapamil is prudent. Some patients with paroxysmal and/or chronic atrial flutter/fibrillation and 
an accessory AV pathway (eg, WPW or LGL syndromes) have developed an increased antegrade 
conduction across the accessory pathway bypassing the AV node. producing a very rapid 
ventricular response or ventricular fibrillation after receiving IV verapamil (or digitalis). Because 
of this risk, oral verapamil is contraindicated in such patients. AV block may occur (2nd· and 
3rd·degree. 0.8%). Development of marked 1st-degree block or progression to 2nd- or 3rd· 
degree block requires reduction in dosage or. rarely, discontinuation and institution of appropriate 
therapy. Sinus bradycardia. 2nd-degree AV block. sinus arrest. pulmonary edema and/or severe 
hypotension were seen in some critically ill patients with hypertrophic cardiomyopathy who were 
treated with verapamil. 
Precaution•: Verapamil should be given cautiously to patients with impaired hepatic function (in severe dysfunction use about 30% of the normal dose) or impaired renal function, and patients 
should be monitored for abnormal prolongation of the PR inteMI or other signs of overdosage. 
Verapamil may decrease neuromuscular transmission in patients with Duchenne's muscular 
dystrophy and may prolong recovery from the neuromuscular blocking agent vecuronium. It may 
be necessary to decrease verapamil dosage in patients with attenuated neuromuscular transmis· 
sion. Combined therapy with beta-adrenergic blockers and verapamil may resuh in additive 
negative effects on heart rate, atrioventricular conduction and/or cardiac contractility; there have 
been reports of excessive bradycardia and AV block, including complete heart block. The risks 
of such combined therapy may outweigh the benefits. The combination should be used only 
with caution and close monitoring. Decreased metoprolol and propranolol clearance may occur 
when either drug is administered concomitantly with verapamil. A variable effect has been seen 
with combined use of atenolol. Chronic verapamil treatment can increase serum digoxin levels 
by 50% to 75% during the first week of therapy, which can result in digitalis toxicity. In patients 
with hepatic cirrhosis, verapamil may reduce total body clearance and extrarenal clearance of 
digitoxin. The digoxin dose should be reduced when verapamil is given, and the patient carefully 
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monitored. Verapamil will usually have an additive effect in patients receiving blood-pressure-
lowering agents. Disopyramide should not be given within 48 hours before or 24 hours after 
verapamil administration. Concomitant use of flecainide and verapamil may have additive effects 
on myocardial contractility, AV conduction, and repolarization. Combined verapamil and quinidine 
therapy in patients with hypertrophic cardiomyopathy should be avoided, since significant 
hypotension may resuh. Concomitant use of lithium and verapamil may resuh in a lowering of 
serum lithium levels or increased sensitivity to lithium. Patients receiving both drugs must be 
monitored carefully. Verapamil may increase carbamazepine concentrations during combined use. 
Aifampin may reduce verapamil bioavailability. Phenobarbital may increase verapamil clearance. 
Verapamil may increase serum levels of cyclosporin . Verapamil may inhibit the clearance and 
increase the plasma levels of theophylline. Concomitant use of inhalation anesthetics and calcium 
antagonists needs careful titration to avoid excessive cardiovascular depression. Verapamil may 
potentiate the activity of neuromuscular blocking agents (curare-like and depolarizing); dosage 
reduction may be required. There was no evidence of a carcinogenic potential of verapamil 
administered to rats for 2 years. A study in rats did not suggest a tumorigenic potential. and 
verapamil was not mutagenic in the Ames test. Pregnancy Category C. There are no adequate 
and well-<:ontrolled studies in pregnant women. This drug should be used during pregnancy. 
labor. and delivery only if clearly needed. Verapamil is excreted in breast milk; therefore. nursing 
should be discontinued during verapamil use. 
Advtl'le Rtactiona: Constipation (7.3%). dizziness (3 .3%). nausea (2.7%). hypotension (2.5%), 
headache (2 .2%), edema (1.9%). CHF. pulmonary edema (1 .8%). fatigue (1.7%), dyspnea (1.4%). 
bradycardia: HR < 50/min (1.4%), AV block: total 1·.2•.3• (1.2%). 2· and 3• (0.8%), rash 
(1.2%). flushing (0.6%). elevated liver enzymes. reversible non-obstructive paralytic ileus. The 
following reactions. reported in 1.0% or less of patients. occurred under conditions where a 
causal relationship is uncertain: angina pectoris, atrioventricular dissociation. chest pain. claudi-
cation. myocardial infarction, palpitations, purpura (vasculitis). syncope, diarrhea, dry mouth, 
gastrointestinal distress, gingival hyperplasia, ecchymosis or bruising. cerebrovascular accident, 
confusion, equilibrium disorders. insomnia. muscle cramps. paresthesia. psychotic symptoms, 
shakiness, somnolence. arthralgia and rash. exanthema. hair loss. hyperkeratosis. maculas, 
sweating. urticaria, Stevens-Johnson syndrome. erythema muhiforme. blurred vision. gyneco· 
mastia. galactorrhea/hyperprolactinemia. increased urination. spotty menstruation. impotence. 
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other training is completed. I believe this system of medical 
education would not only increase the number of applicants to 
medical school but also improve their quality. 
Nursing education should also be subsidized. Nursing stu-
dents should be required to spend several years bedside nurs-
ing before any specialization leading to a degree would occur. 
If higher degrees are desired, the nurse should be directed 
toward medical school. Other providers would receive appro-
priate subsidized education and training. As with physicians, 
income would be capped. 
The last proposition is that all suits for alleged malpractice, 
Rabies 
The case report in this issue of the Journal, by veterinarian 
David Sasaki of the State Department of Health and others, 
gives proof positive of the value of Hawaii's animal quaran-
tine program. 
Hawaii's program has withstood assaults from many direc-
tions and by many people who are more concerned about their 
own pets than they are about the lethal scourge of the rabies 
virus, should it become prevalent in our state and affect the 
general public. As the authors of this article point out clearly, 
Hawaii is only one of 4 places where so far rabies is nonexis-
tent; the other 3 are Australia, Great Britain and New Zealand. 
The other 49 states of the U.S. are not -repeat, not-free of 
Medicine is not pure science 
As the practice of medicine enters the era of the market-
place, it not only has to maintain its status as a science ever 
striving for credibility, but also as the art of healing. The latter 
has elicited increasing attention the past decade or two as 
more and more people - our patients - demand an approach 
to the whole person, rather than to a body made up of organs 
and parts. As if that weren't enough, the medical profession 
needs to become versed in the economics of doing business 
and abiding by the stacks of rules and regs that govern the 
marketplace. All of this is rather overwhelming for the doctor 
who wishes to concentrate purely on helping people recover 
from their disabilities. 
The physician needs a break; he or she needs to have their 
batteries recharged at intervals. 
The conferences that David Elpern has spearheaded on 
Kauai and Molokai are just that: Moments in which to relax, 
consider one's professional career from afar and look to the 
horizon of the future, personally as well as professionally. 
They almost always include science, art and the marketplace. 
In this issue of the Journal, we call the reader's attention to 
Elpem's introductory remarks that he gave to some 125 regis-
trants at "Health Matters," a 4-day conference at beautiful and 
spectacular Poipu on Kauai. 
We noted and reacted favorably to his subtle but not so 
gentle remarks on the subject of getting accreditation for the 
registrations from the medical powers that be, namely the 
HMA and the JABSOM at UH. Those "bean-counters", as he 
calls them, are a necessity in order to preserve our credibility, 
we earthlings of dubious honesty, but they are sticklers for 
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either by omission or by commission, should be settled by 
mandatory binding arbitration with all legal fees to be paid by 
the claimant (unless arbitrated), but however derived, capped. 
At least part of this proposition is in place and being used by 
some providers. Besides not providing medical care for all, 
the United States is the only country in the developed world 
wherein lawyers may charge contingency fees. 
the dread disease. 
John B Dillon MD 
Guest editor from Kauai 
The authors, Drs. Sasaki and Sawa, and Messrs. Kobayashi 
and Middleton of the DoH, and Christensen of the Department 
of Agriculture, are to be commended for a job well done and 
for an excellent report: "Rabid bat diagnosed in Hawaii". 
Included in our commendation are the people of Sea Land 
Hawaii, the shipping firm, and those from Hawaii Stevedores 
Inc, without whose immediate and full cooperation the rabid 
bat might have eluded surveillance. 
J I Frederick Reppun MD 
Editor 
rules that rarely let the art supercede the science of medicine. 
We like the way David Elpem brings together the physi-
cian and the patient becoming better known impersonally 
nowadays as the health care provider and the consumer (ugh!). 
We like the way he brings together our essential para-profes-
sionals: Nurses, therapists, social workers and others, who 
often have an intermediary role and are sometimes closer to 
the patient than is the physician, alas; brings them into the 
same intimate and friendly milieu of a conference in a beauti-
ful spot where Nature holds sway. 
This particular conference took place on a part of Hawaii 
that is in the national limelight. Hawaii's people are con-
cerned that the projected interceptor missile program funded 
by Star Wars at the PMRF at Barking Sands will pose a threat 
to the people and the environment. A pertinent diversion at the 
conference was in response to a request from Responsible 
People for Responsible Government, spark-plugged by Liz 
Freeman. It was an evening session at which Victor Sidel MD, 
distinguished Professor of Social Medicine at Einstein College 
of Medicine in New York and a member of the IPPNW dele-
gation that received the Nobel Peace Prize in Oslo in 1985, 
spoke at the Lihue Parish Hall. He later met with Senator 
Inouye who promised to do what he could to protect Kauai 
and its people. Physicians have a social responsibility, no less! 
We hope that David will neither quit nor bum out. We urge 
readers to give the Kauai Foundation for Continuing 
Education their sincere support. 
J I Frederick Reppun MD 
Editor 
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